Individual presentation recordings
Tuesday 24 November 09:00 - 11:40: Session 1
| Session 1 | HIV: think globally, act locally | |
|---|---|---|
| Chairs: Frank Cobelens (Amsterdam UMC-AMC; AIDHG) & Kim Sigaloff (Amsterdam UMC-VUmc) | ||
| 09:00 - 09:10 | Welcome and introductions | Peter Reiss (SHM; Amsterdam UMC-AMC; AIGHD) Kim Sigaloff (Amsterdam UMC-VUmc) |
| 09:10 - 09:30 | Plenary: Tuberculosis in the face of two global viral pandemics | Sabine Hermans (AIGHD; Amsterdam UMC-AMC) |
| 09:30 - 09:40 | Moderated Q&A | |
| 09:40 - 10:05 | Promoting indicator condition-guided testing for HIV in the hospital setting (PROTEST 2.0): Baseline results of a multicentre intervention study | Saskia Bogers (Amsterdam UMC-AMC) |
| Improving the HIV testing cascade: adequate identification of patients with HIV indicator conditions in hospitals by electronic registration systems On behalf of the #AWARE.hiv project group | Carlijn Jordans (Erasmus MC) | |
| Large regional variation across the Netherlands in the number of people living with undiagnosed HIV | Ard van Sighem (SHM) | |
| 10:05 - 10:15 | Moderated Q&A | |
| 10:15 - 10.25 | Short break | |
| 10:25 - 10:45 | Highlights 2020 NL HIV Monitoring Report | Ard van Sighem SHM) Colette Smit (SHM) Ferdinand Wit (SHM; Amsterdam UMC-AMC) Anders Boyd (GGD Amsterdam; SHM) |
| 10:45 - 11:05 | Panel discussion 2020 NL Monitoring Report. We have the data... what's next? | Anders Boyd (GGD Amsterdam; SHM) Ard van Sighem SHM) Colette Smit (SHM) Ferdinand Wit (SHM; Amsterdam UMC-AMC) Moderators: Kim Sigaloff (Amsterdam UMC-VUmc) Mark Vermeulen (Aidsfonds) |
| 11:05 - 11:10 | Close | |
| 11:10 - 11:45 | Parallel oral poster presentations of 5 minutes each followed by non-moderated Q&A (see separate dropdown) | |
| 11:45 - 15:00 | Lunch break & various sponsor sessions | |
| 11:45 - 12:45: ViiV 12:00 - 12:30: Gilead 11:45 - 12:45: MSD |
||
Tuesday 24 November 15:00 - 17:15: Session 2
| Session 2 | Antiretroviral therapy: novel options and how to implement them | |
|---|---|---|
| Chairs: Jet Gisolf (Rijnstate) & Marc van der Valk (Amsterdam UMC-AMC) | ||
| 15:00 - 15:05 | Welcome and introductions | |
| 15:05 - 15:25 | Plenary: Novel Antiretroviral Treatments and Strategies | Daniel Kuritzkes (Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA) |
| 15:25 - 15:35 | Moderated Q&A | |
| 15:35 - 16:00 | Lower incidence of viral blips: another finding to favor the use of INSTI-based cART | Suzan Dijkstra (UMC Utrecht) |
| A population pharmacokinetic analysis assessing the exposure of raltegravir once-daily 1200mg in pregnant women living with HIV | Vera Bukkems (Radboudumc) | |
| Prevalence, correlates and health impact of healthcare provider counseling about undetectable equals untransmittable (u=u): findings from the Netherlands and other European Countries | Bart Lammertink (ViiV Healthcare) | |
| 16:00 - 16:10 | Moderated Q&A | |
| 16:10 - 16:20 | Short break | |
| 16:20 - 17:00 | Panel: Implementing long-acting antivirals for treatment and prevention in practice | Renee Finkenflügel (Hiv vereniging) Emilie Gieling (UMC Utrecht) Noëmi Nijsten GGD Gelderland-Zuid Karin Grintjes (Radboudumc) Sjoerd Repping (Amsterdam UMC-AMC; Zorginstituut Nederland Moderator: Marc van der Valk (Amsterdam UMC-AMC) |
| 17:00- 17:05 | Close | |
Thursday 26 November 09:00 - 11:40: Session 3
| Session 3 | Curing HIV and hepatitis: now and in the future | |
|---|---|---|
| Chairs: Marit van Gils (Amsterdam UMC-AMC) & Casper Rokx (Erasmus MC) | ||
| 09:00 - 09:10 | Welcome and introductions | |
| 09:10 - 09:30 | Plenary: Advances towards an HBV cure: lessons for HIV cure strategies | Sharon Lewin (University of Melbourne, Australia) |
| 09:30 - 09:40 | Moderated Q&A | |
| 09:40 - 10:05 | HCV micro-elimination in HIV-positive individuals in the Netherlands: four years after universal access to direct-acting antivirals | Colette Smit (SHM) |
| HIV-specific CD8+ T-cells from elite controllers display a gene expression profile associated with increased functionality | Lisa van Pul (Amsterdam UMC-AMC) | |
| Antibody engineering to improve Fc effector function and therapeutic application of HIV-1 bNAbs | Steven de Taeye (Amsterdam UMC-AMC) | |
| 10:05 - 10:15 | Moderated Q&A | |
| 10:15 - 10:25 | Short break | |
| 10:25 - 10:50 | Locking & Unlocking Sexual Health for MSM | Moderators: Febe Deug (Aidsfonds) & Vanessa Harris (Amsterdam UMC-AMC; AIGHD) |
| Impact of COVID-19 measures on patterns of sexual activity and risk of HIV or STI acquisition among MSM living in the Netherlands | Philippe Adam (Institute for Prevention and Social Research in Health ) | |
| The effect of COVID-19 restrictions on daily sexual behavior and pre-exposure prophylaxis use among men who have sex with men | Vita Jongen (GGD Amsterdam) | |
| Never tested for HIV: directions for a targeted testing intervention among men who have sex with men | Hanne Zimmermann (GGD Amsterdam) | |
| 10:50 - 11:00 | Moderated Q&A | |
| 11:00 - 11:05 | Close | |
| 11:05 - 11:40 | Parallel oral poster presentations of 5 minutes each followed by non-moderated Q&A (see separate dropdown) | |
| 11:40 - 15:00 | Lunch break & various sponsor sessions | |
| 11:45 - 12:40: ViiV 11:55 - 12:25 Gilead 11:40 - 12:40: MSD |
||
Thursday 26 November 15:00 - 17:30: Session 4
| Session 4 | HIV prevention and cure: how to best serve the client and outsmart the virus |
|
|---|---|---|
| Chairs: Godelieve de Bree & Marit van Gils (Amsterdam UMC-AMC) | ||
| 15:00 - 15:05 | Welcome and introductions |
|
| 15:05 - 15:25 | Plenary: What Participants Know: The Critical Role of Socio-Behavioral Sciences in HIV Cure Research | Karine Dubé (University of North Carolina, Gillings School of Public Health, USA) |
| 15:25 - 15:35 | Moderated Q&A | |
| 15:35 - 16:00 | HIV-1 Subverts the complement system to escape degradation and promote viral dissemination | Marta Bermejo Jambrina (Amsterdam UMC-AMC) |
| Changes in condomless anal sex and sexually transmitted infections after PrEP initiation among men who have sex with men: a comparison of PrEP users to non-PrEP users | Liza Coyer (GGD Amsterdam) | |
| Enhancing and directing neutralizing antibody responses by ultrastabilization of HIV-1 envelope trimers and masking immunodominant epitopes | Iván del Moral Sánchez (Amsterdam UMC-AMC) | |
| 16:00 - 16:10 | Moderated Q&A | |
| 16:10 - 16:15 | Award ceremony: 2020 Joep de Lange & Jacqueline van Tongeren Award | |
| 16:15 - 16:25 | Short break | |
| 16:25 - 17:25 | The tale of two pandemics, what can one teach us in facing the other? (This session will be held in Dutch) | A conversation between Yvonne van Duijnhoven (Head of Infectious disease control Public Health Services) and Roel Coutinho (former head of Public Health Service Amsterdam, and former Director or the National Institute for Public Health and the Environment), led by Coen Verbraak (journalist and program director) |
| 17:25 - 17:30 | Close | Marit van Gils (Amsterdam UMC-AMC) Peter Reiss (SHM; Amsterdam UMC-AMC; AIGHD) Kim Sigaloff (Amsterdam UMC-VUmc) |
Parallel oral poster presentations (during sessions 1 & 3)